Even after a resurrected sales approval from the Federal Drug Administration Authority in the US Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)'s shares are still facing the brunt of the October recall of Iclugis. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) rose 5.56% to $8.35 yesterday on volume of 13.61 million shares. The intra-day range of the stock was $7.91 – $8.42. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has a market capitalization of 1.55 billion. Idera Pharmaceuticals (NASDAQ:IDRA) issued its quarterly earnings data on Thursday. The company reported ($0.10) earnings per share for the quarter, missing the analysts' consensus estimate of ($0.08) by $0.02, Stock Ratings Network reports. Idera Pharmaceuticals Inc. (NASDAQ:IDRA)'s stock on March 18, 2014 reported a higher of 8.75% to the closing price of $6.59. Its fifty two weeks range is $0.43 – $6.87. The total market capitalization recorded 301.29 million. The overall volume in the last trading session was 7.65 million shares.